Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-15

Clinical Trial Update: A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for glycopyrronium cloth 2.4% in palmar hyperhidrosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • glycopyrronium cloth 2.4% (glycopyrronium)

Snippet

Sponsor: Journey Medical Corporation | Conditions: Palmar Hyperhidrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-03-15